XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Class A and Class B Common Stock
Class A and Class B Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance, shares at Dec. 31, 2020       305,880,063 305,880,063                
Beginning balance at Dec. 31, 2020 $ 957,432 $ (156,268) $ 801,164 $ 3 $ 3 $ 1,103,305 $ (173,070) $ 930,235 $ 2,287 $ 2,287 $ (148,163) $ 16,802 $ (131,361)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock upon exercise of stock options (in shares)       2,530,629                  
Issuance of common stock upon exercise of stock options 6,217         6,217              
Vesting of early exercised stock options 500         500              
Vesting of restricted stock units (in shares)       789,210                  
Issuance of restricted shares of common stock from acquisition (in shares)       501,583                  
Issuance of restricted shares of common stock from acquisitions 51,501         51,501              
Issuance of common stock under the Employee Stock Purchase Plan (in shares)       139,649                  
Issuance of common stock under the Employee Stock Purchase Plan 9,794         9,794              
Stock-based compensation 67,588         67,588              
Change in accumulated other comprehensive income (loss) (1,455)               (1,455)        
Net (loss) income (22,430)                   (22,430)    
Ending balance, shares at Jun. 30, 2021       309,841,134                  
Ending balance at Jun. 30, 2021 912,879     $ 3   1,065,835     832   (153,791)    
Beginning balance, shares at Mar. 31, 2021       307,804,350                  
Beginning balance at Mar. 31, 2021 841,330     $ 3   985,004     752   (144,429)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock upon exercise of stock options (in shares)       1,210,516                  
Issuance of common stock upon exercise of stock options 2,928         2,928              
Vesting of early exercised stock options 206         206              
Vesting of restricted stock units (in shares)       440,858                  
Issuance of restricted shares of common stock from acquisition (in shares)       245,761                  
Issuance of restricted shares of common stock from acquisitions 31,329         31,329              
Issuance of common stock under the Employee Stock Purchase Plan (in shares)       139,649                  
Issuance of common stock under the Employee Stock Purchase Plan 9,794         9,794              
Stock-based compensation 36,574         36,574              
Change in accumulated other comprehensive income (loss) 80               80        
Net (loss) income (9,362)                   (9,362)    
Ending balance, shares at Jun. 30, 2021       309,841,134                  
Ending balance at Jun. 30, 2021 912,879     $ 3   1,065,835     832   (153,791)    
Beginning balance, shares at Dec. 31, 2021       313,365,437                  
Beginning balance at Dec. 31, 2021 $ 1,041,203     $ 3   1,197,136     (3,830)   (152,106)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock upon exercise of stock options (in shares) 1,673,753     1,673,753                  
Issuance of common stock upon exercise of stock options $ 6,416         6,416              
Vesting of early exercised stock options 33         33              
Vesting of restricted stock units (in shares)       1,039,058                  
Issuance of restricted shares of common stock from acquisition (in shares)       191,019                  
Issuance of restricted shares of common stock from acquisitions 7,608         7,608              
Issuance of common stock under the Employee Stock Purchase Plan (in shares)       146,515                  
Issuance of common stock under the Employee Stock Purchase Plan 13,557         13,557              
Stock-based compensation 156,123         156,123              
Change in accumulated other comprehensive income (loss) (14,679)               (14,679)        
Net (loss) income 4,859                   4,859    
Ending balance, shares at Jun. 30, 2022       316,415,782                  
Ending balance at Jun. 30, 2022 1,215,120     $ 3   1,380,873     (18,509)   (147,247)    
Beginning balance, shares at Mar. 31, 2022       314,921,005                  
Beginning balance at Mar. 31, 2022 1,116,857     $ 3   1,271,777     (12,555)   (142,368)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock upon exercise of stock options (in shares)       506,753                  
Issuance of common stock upon exercise of stock options 2,198         2,198              
Vesting of restricted stock units (in shares)       650,490                  
Issuance of restricted shares of common stock from acquisition (in shares)       191,019                  
Issuance of restricted shares of common stock from acquisitions 7,608         7,608              
Issuance of common stock under the Employee Stock Purchase Plan (in shares)       146,515                  
Issuance of common stock under the Employee Stock Purchase Plan 13,557         13,557              
Stock-based compensation 85,733         85,733              
Change in accumulated other comprehensive income (loss) (5,954)               (5,954)        
Net (loss) income (4,879)                   (4,879)    
Ending balance, shares at Jun. 30, 2022       316,415,782                  
Ending balance at Jun. 30, 2022 $ 1,215,120     $ 3   $ 1,380,873     $ (18,509)   $ (147,247)